A Landscape of Artificial Intelligence (AI) In Pharmaceutical R&D

Where you find opportunities to grow

* Can't find your brand, product, service? Join BPT Marketplace

CPhI South East Asia rescheduled for 2021

   by Abdul Khalifeh, Contributor    75    Comments 0

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com.
Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

CPhI South East Asia – organised by Informa Markets – has been rescheduled to May 18-20, 2021 to give the ASEAN pharma community more time to recover and to mitigate any global disruptions caused by COVID-19.

 “The decision to reschedule the event to 2021 reflects changing attendee needs. By moving to spring next year, we will enable exhibitors and visitors to get the maximum amount of value from the show. A 2021 CPhI South East Asia will deliver reassurance to our community and alleviate many of the logistical challenges for overseas visitors. We consulted with our stakeholders and this change will empower greater numbers and a more inclusive event for the Southeast Asian pharma community,” commented Silvia Forroova, Brand Director at Informa Markets.

The event will return to the Impact, Muang Thong, Thani in Bangkok (Thailand) and further details will be available shortly. To help the region’s pharma industry continue to meet, connect and conduct new business, Informa is also creating a comprehensive CPhI South East Asia Online Business Matchmaking Platform. The new online platform will facilitate unlimited connections and break through the physical restrictions.

We understand the vital role our events play in facilitating new business and networking. So we are now working on a dedicated online business matchmaking tool to empower our Southeast Asia pharma community. But, we will also use the additional time to develop a show that will be well worth the wait and you can be assured that we are continually striving to find new ways to engage and support you. Thank you to all our exhibitors and partners for their incredible support.” added Forroova. 

About CPhI

CPhI drives growth and innovation at every step of the global pharmaceutical supply chain from drug discovery to finished dosage. Through exhibitions, conferences and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities and expand the global market. CPhI hosts events in Europe, Korea, China, India, Japan, South East Asia, North America, and the Middle East and Africa. Co-locating with ICSE for contract services; P-MEC for machinery, equipment & technology; InnoPack for pharmaceutical packaging; bioLIVE for biopharma; Finished Dosage Formulation for every aspect of the finished dosage supply chain; and NEX for natural extract products, applications and solutions.  CPhI provides an online buyer and supplier directory at CPhI-Online.com.

For more information visit https://www.cphi.com

About Informa Markets

Informa Markets creates platforms for industries and specialist markets to trade, innovate and grow. Our portfolio is comprised of more than 550 international B2B events and brands in markets including Healthcare & Pharmaceuticals, Infrastructure, Construction & Real Estate, Fashion & Apparel, Hospitality, Food & Beverage, and Health & Nutrition, among others. We provide customers and partners around the globe with opportunities to engage, experience and do business through face-to-face exhibitions, specialist digital content and actionable data solutions. As the world’s leading exhibitions organiser, we bring a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year.

For more information, please visit www.informamarkets.com.

For media enquiries, please contact:

Alex Heeley or Abdul Khalifeh

De Facto Communications

T: +44 (0) 203 735 8168

E: a.heeley@defacto.co.uk / a.khalifeh@defacto.co.uk

Share this:              
A Landscape of Artificial Intelligence (AI) In Pharmaceutical R&D
 

Comments:

There are no comments yet. You can be the first.

Leave a Reply

Your email address will not be published. Required fields are marked *